Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on gastroenteropancreatic neuroendocrine tumors
Valentina Andreasi, Stefano Partelli, Francesca Muffatti, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 2, pp. 171-182
Closed Access | Times Cited: 98

Showing 26-50 of 98 citing articles:

Pancreatic Neuroendocrine Diagnostic Imaging Order and Reader Evaluation over Two Decades in a Tertiary Academic Center
Sara Babapour, A.M. Chen, Grace Li, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 960-960
Open Access
Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy
Deborah Pencharz, Gopinath Gnanasegaran, Shaunak Navalkissoor
British Journal of Radiology (2018) Vol. 91, Iss. 1091, pp. 20180108-20180108
Open Access | Times Cited: 31
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials
Mauro Cives, Heloisa P. Soares, Jonathan Strosberg
Current Opinion in Oncology (2016) Vol. 28, Iss. 4, pp. 359-366
Closed Access | Times Cited: 28
Surgical treatment for gastrointestinal neuroendocrine tumors
Kojiro Eto, Naoya Yoshida, Shiro Iwagami, et al.
Annals of Gastroenterological Surgery (2020) Vol. 4, Iss. 6, pp. 652-659
Open Access | Times Cited: 25
Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms
Andrew Canakis, Linda Lee
World Journal of Gastrointestinal Endoscopy (2022) Vol. 14, Iss. 5, pp. 267-290
Open Access | Times Cited: 16
Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study
Xinwei Li, Yongfei Fan, Jichun Tong, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
Edward M. Wolin, Amandine Manon, Christophe Chassaing, et al.
Journal of Gastrointestinal Cancer (2016) Vol. 47, Iss. 4, pp. 366-374
Open Access | Times Cited: 26
NETs: organ-related epigenetic derangements and potential clinical applications
Mauro Cives, Valeria De Simone, Francesca Rizzo, et al.
Oncotarget (2016) Vol. 7, Iss. 35, pp. 57414-57429
Open Access | Times Cited: 25
Osteotropism of neuroendocrine tumors: role of the CXCL12/CXCR4 pathway in promoting EMT in vitro
Mauro Cives, Davide Quaresmini, Francesca Rizzo, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 22534-22549
Open Access | Times Cited: 25
Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms
Davorka Herman Mahečić, Maja Cigrovski Berković, Vanja Zjačić-Rotkvić, et al.
Bosnian Journal of Basic Medical Sciences (2020)
Open Access | Times Cited: 22
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study
Gianluca Esposito, Maria Cazzato, Maria Rinzivillo, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 7, pp. 890-895
Open Access | Times Cited: 20
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors
Mauro Cives, Daniel A. Anaya, Heloisa P. Soares, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 3, pp. 282-289
Open Access | Times Cited: 23
Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
Takayuki Miura, Hideo Ohtsuka, Takeshi Aoki, et al.
BMC Surgery (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms
Anna Battistella, Matteo Tacelli, Paola Mapelli, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 4-5, pp. 155-169
Closed Access | Times Cited: 2
Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias
Argyrios Periferakis, Georgios Tsigas, Aristodemos-Theodoros Periferakis, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9721-9759
Open Access | Times Cited: 2
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
Rossana Berardi, Francesca Morgese, Mariangela Torniai, et al.
World Journal of Gastrointestinal Oncology (2016) Vol. 8, Iss. 4, pp. 389-389
Open Access | Times Cited: 19
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms
Javier Pozas, María San Román, Teresa Alonso‐Gordoa, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4949-4949
Open Access | Times Cited: 18
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors
Martine Bocchini, Marcella Tazzari, Sara Ravaioli, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors
Jose Eduardo Nuñez, Mauro Daniel Spina Donadio, Duilio Rocha Filho, et al.
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 645-651
Open Access | Times Cited: 17
Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
Zhihao Zhou, Zhixiong Wang, Bing Zhang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 13
Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 10
The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors
Agnieszka Milewska-Kranc, Jarosław B. Ćwikła, Agnieszka Kolasińska-Ćwikła
Cancers (2023) Vol. 16, Iss. 1, pp. 116-116
Open Access | Times Cited: 5
The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
Mirela Gherghe, Alexandra Maria Lazăr, A Stanciu, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2725-2725
Open Access | Times Cited: 9
Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis
Martin A. Walter, Cédric Nesti, Marko Spanjol, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 11
Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
Deng Han, Yuanliang Li, Zhiwei Zhou, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 21, pp. 2895-2909
Open Access | Times Cited: 11

Scroll to top